Description
Product Description
Neo-Mercazole 5 Tablet is an antithyroid medicine used in the treatment of hyperthyroidism (overactive thyroid) and Graves’ disease. It helps regulate excessive thyroid hormone production, which can cause symptoms like rapid heartbeat, weight loss, sweating, tremors, and nervousness.
It is often prescribed before thyroid surgery or radioactive iodine therapy to stabilize hormone levels. Regular monitoring of thyroid function and blood counts is essential during treatment.
Uses:
Treatment of hyperthyroidism
Management of Graves’ disease
Preparation before thyroid surgery
Pre-treatment before radioactive iodine therapy
Key Benefits:
Controls overproduction of thyroid hormones
Improves symptoms like nervousness, palpitations, and weight loss
Helps restore metabolic balance
Useful in preoperative thyroid stabilization
Dosage
As directed by your doctor based on thyroid hormone levels
Swallow whole with water at the same time each day
Do not skip doses or stop abruptly
How Neo-Mercazole 5 Tablet Works
Carbimazole inhibits the thyroid peroxidase enzyme, reducing the production of T3 and T4 hormones, thus helping bring thyroid levels back to normal.
Side Effects
Common:
Nausea, upset stomach
Rash, itching
Joint pain
Serious (seek immediate help):
Fever, sore throat
Unexplained bruising or bleeding
Yellowing of skin/eyes (possible liver issues)
Precautions & Warnings
Take under medical supervision only
Regular blood and thyroid tests required
Use in pregnancy only if prescribed
Avoid if allergic to Carbimazole
Report unusual symptoms immediately
Storage Instructions
Store below 30°C
Keep in a cool, dry place
Away from children’s reach
FAQs:
Q1: What is Neo-Mercazole 5 used for?
It is used to treat hyperthyroidism and Graves’ disease by reducing thyroid hormone levels.
Q2: How long should I take it?
Duration depends on your doctor’s advice and thyroid test results.
Q3: Can I take it during pregnancy?
Only under medical advice after evaluating risks and benefits.







Reviews
There are no reviews yet.